Annual Long Term Debt
$11.19 M
+$2.85 M+34.18%
31 December 2023
Summary:
Barinthus Biotherapeutics annual long term debt is currently $11.19 million, with the most recent change of +$2.85 million (+34.18%) on 31 December 2023. During the last 3 years, it has fallen by -$34.98 million (-75.76%). BRNS annual long term debt is now -75.76% below its all-time high of $46.17 million, reached on 01 December 2020.BRNS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$10.68 M
+$29.00 K+0.27%
30 September 2024
Summary:
Barinthus Biotherapeutics quarterly long term debt is currently $10.68 million, with the most recent change of +$29.00 thousand (+0.27%) on 30 September 2024. Over the past year, it has dropped by -$519.00 thousand (-4.63%). BRNS quarterly long term debt is now -76.86% below its all-time high of $46.17 million, reached on 01 December 2020.BRNS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BRNS Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.2% | -4.6% |
| 3 y3 years | -75.8% | +38.2% |
| 5 y5 years | - | - |
BRNS Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -75.8% | +71.1% | -4.6% | +66.8% |
| 5 y | 5 years | -75.8% | +596.9% | -76.9% | +671.9% |
| alltime | all time | -75.8% | +596.9% | -76.9% | +671.9% |
Barinthus Biotherapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $10.68 M(+0.3%) |
| June 2024 | - | $10.65 M(-2.2%) |
| Mar 2024 | - | $10.90 M(-2.6%) |
| Dec 2023 | $11.19 M(+34.2%) | $11.19 M(-0.1%) |
| Sept 2023 | - | $11.20 M(+1.4%) |
| June 2023 | - | $11.04 M(+10.4%) |
| Mar 2023 | - | $10.01 M(+20.0%) |
| Dec 2022 | $8.34 M | $8.34 M(+3.3%) |
| Sept 2022 | - | $8.07 M(-2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $8.31 M(+29.8%) |
| Mar 2022 | - | $6.40 M(-2.1%) |
| Dec 2021 | $6.54 M(-85.8%) | - |
| Dec 2021 | - | $6.54 M(-15.4%) |
| Sept 2021 | - | $7.73 M(+458.4%) |
| June 2021 | - | $1.38 M(-3.6%) |
| Mar 2021 | - | $1.44 M(-96.9%) |
| Dec 2020 | $46.17 M(+2775.3%) | $46.17 M |
| Dec 2019 | $1.61 M | - |
FAQ
- What is Barinthus Biotherapeutics annual long term debt?
- What is the all time high annual long term debt for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual long term debt year-on-year change?
- What is Barinthus Biotherapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly long term debt year-on-year change?
What is Barinthus Biotherapeutics annual long term debt?
The current annual long term debt of BRNS is $11.19 M
What is the all time high annual long term debt for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual long term debt is $46.17 M
What is Barinthus Biotherapeutics annual long term debt year-on-year change?
Over the past year, BRNS annual long term debt has changed by +$2.85 M (+34.18%)
What is Barinthus Biotherapeutics quarterly long term debt?
The current quarterly long term debt of BRNS is $10.68 M
What is the all time high quarterly long term debt for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly long term debt is $46.17 M
What is Barinthus Biotherapeutics quarterly long term debt year-on-year change?
Over the past year, BRNS quarterly long term debt has changed by -$519.00 K (-4.63%)